| PERIOD ENDING | 28-Nov-08 | 30-Nov-07 | 1-Dec-06 | | Total Revenue | 3,579,889 | 3,157,881 | 2,575,300 | | Cost of Revenue | 362,630 | 354,694 | 292,457 | | | Gross Profit | 3,217,259 | 2,803,187 | 2,282,843 | | | Operating Expenses | | Research Development | 662,057 | 613,242 | 539,684 | | Selling General and Administrative | 1,426,632 | 1,259,370 | 1,102,260 | | Non Recurring | 32,053 | 555 | 19,733 | | Others | 68,246 | 72,435 | 69,873 | | | | Total Operating Expenses | 2,188,988 | 1,945,602 | 1,731,550 | | | | Operating Income or Loss | 1,028,271 | 857,585 | 551,293 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 60,256 | 89,858 | 128,434 | | Earnings Before Interest And Taxes | 1,088,527 | 947,443 | 679,727 | | Interest Expense | 10,019 | 253 |
-
| | Income Before Tax | 1,078,508 | 947,190 | 679,727 | | Income Tax Expense | 206,694 | 223,383 | 173,918 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 871,814 | 723,807 | 505,809 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 871,814 | 723,807 | 505,809 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $871,814 | $723,807 | $505,809 |
|
1.48% Nasdaq 
Income Statement
